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Summary
Nucleophosmin (NPM, B23) is an abundant nucleolar phosphoprotein involved in ribosome biogenesis, and interacts with
tumor suppressor proteins p53 and Rb. Here we show that NPM is a UV damage response protein that undergoes
nucleoplasmic redistribution and regulates p53 and HDM2 levels and their interaction. By utilizing RNAi approaches and
analyses of endogenous and ectopically expressed proteins, we demonstrate that NPM binds HDM2 and acts as a negative
regulator of p53-HDM2 interaction. Viral stress, enforced by expression of Kaposi’s sarcoma virus K cyclin, causes NPM
redistribution, K cyclin-NPM association, and p53 stabilization by dissociation of HDM2-p53 complexes. The results demon-
strate novel associations of HDM2 and K cyclin with NPM and implicate NPM as a crucial controller of p53 through inhibition
of HDM2.
Introduction 2003). There is, however, no evidence that phosphorylation
events are involved in the NPM stress responses. NPM exists
Nucleophosmin (NPM, B23, numatrin, NO38) is a nucleolar in two heavily phosphorylated splicing variants, NPM1 and
phosphoprotein constantly shuttling between the nucleolus and NPM1.2 (B23.1 and B23.2, respectively), which form multimers
cytoplasm (Borer et al., 1989). It functions as a ribosomal assem- (Chang and Olson, 1989; Umekawa et al., 1993). NPM1 is mostly
bly and transport protein (Spector et al., 1984; Yung et al., nucleolar, while NPM1.2 is present in cells in low levels and is
1985; Borer et al., 1989), binds to proteins containing nuclear detected both in cytoplasm and nucleoplasm (Wang et al., 1993;
localization signals (NoLS) for their import (Szebeni et al., 1995), Okuwaki et al., 2002). The differences in their localization pat-
acts as a molecular chaperone (Szebeni and Olson, 1999; Oku- terns are due to the absence of C-terminal 35 amino acids in
waki et al., 2001), and is essential in centrosome duplication NPM1.2, which mediate the RNA binding and RNase activities
(Okuda et al., 2000). Nucleolar translocation of NPM occurs in of NPM1 (Wang et al., 1994; Okuwaki et al., 2002). The main
mitosis as the nucleolus disappears in the prophase (Ochs et
function of NPM1 is in ribosome biogenesis, while the function
al., 1983; Zatsepina et al., 1997; Dundr et al., 2000). This is
of NPM1.2 is not well understood (Savkur and Olson, 1998;coupled with phosphorylation of NPM by CDK1/cyclin B during
Herrera et al., 1995). NPM binds several cellular and viral pro-mitosis (Peter et al., 1990). NPM binds to centrosomes, and its
teins, including nucleolin, which is another nucleolar phospho-interaction is dissociated by its phosphorylation on threonine
protein (Li et al., 1996), human immunodeficiency virus (HIV)199 by CDK2/cyclin E, which initiates centrosomal duplication
Rev and Tat proteins (Fankhauser et al., 1991; Li, 1997), hepatitis(Okuda et al., 2000; Tokuyama et al., 2001; Tarapore et al., 2002).
delta virus delta antigens (Huang et al., 2001), retinoblastomaPhosphorylation of NPM by CDK2/cyclin E also decreases its
protein (Takemura et al., 1999), and recently, p53 (Colombo etRNA binding activity (Okuwaki et al., 2002).
al., 2002). NPM association with p53 regulates the stability andNPM is redistributed from the nucleolus in response to cyto-
activity of p53, although the mechanism is unresolved (Colombotoxic drugs and genotoxic stress like inhibition of RNA polymer-
et al., 2002). In addition, noting its function in ribosome biogene-ase I, DNA intercalating agents, and UV damage (Wu and Yung,
2002; Wu et al., 2002a; Yang et al., 2002; Rubbi and Milner, sis, NPM associates with a large RNA-ribonucleoprotein com-
S I G N I F I C A N C E
The turnover rate of p53, mediated through the proteasome pathway and effected by HDM2, is the major route controlling p53 levels
and is specifically abrogated in DNA-damaged cells. We identify here a major cascade of UV damage-provoked changes initiated
by the subcellular redistribution of NPM and its enhanced association with HDM2 leading to the release of p53 from HDM2-mediated
negative pressure. We demonstrate that a similar NPM-mediated set of events controls p53 in viral stress induced by KSHV K cyclin
expression. The results underline the significance of NPM in the control of p53 and warrant further studies of its relevance in human
tumors.
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plex containing nucleolin, fibrillarin, and several ribosomal pro- earlier by Wu and Yung (2002). The UV-induced effects on NPM
were time- and dose-dependent, being more pronounced withteins (Pinol-Roma, 1999).
Human MDM2 (HDM2) is a nucleoplasmic and nucleolar higher doses of UV (10 J/m2, results not shown). Similar UV-
induced translocations of other nucleolar proteins, nucleolin,RING-finger protein interacting with several tumor suppressor
proteins, including p53, retinoblastoma protein, p14ARF (here- and Ki-67 were also observed (data not shown).
after ARF for alternative reading frame), and promyelocytic leu-
kemia protein (PML) (Barak and Oren, 1992; Momand et al., HDM2 interacts with NPM through its amino-
and carboxytermini1992; Haines et al., 1994; Xiao et al., 1995; Kamijo et al., 1998;
Wei et al., 2003; Kurki et al., 2003). HDM2 controls the levels of As HDM2 is a damage-responsive protein, binds ribosomal pro-
teins L5 and L11 (Marechal et al., 1994; Lohrum et al., 2003;p53 by acting as an E3 ubiquitin ligase initiating p53 proteasomal
degradation, and possesses autoubiquitin activity (Honda et al., Zhang et al., 2003), and localizes to nucleoli during proteasomal
stress (Klibanov et al., 2001; Xirodimas et al., 2001; Latonen et1997; Honda and Yasuda, 2000; Fang et al., 2000). The potent
activity of p53 as inducer of cellular apoptosis and cell cycle al., 2003), we wanted to address a possible interaction between
NPM and HDM2 following inhibition of the proteasome. In un-arrest demands tight control for its function. The major mode
for provoking p53 action is DNA damage, which leads to the stressed cells, HDM2 has a diffuse nucleoplasmic staining, while
MG132-treatment of p53 null SaOS-2 cells caused a partialrelease of interaction between HDM2 and p53, increasing p53
stability and activity (Vousden and Lu, 2002). p53 activity is also translocation of HDM2 to the nucleoli and its colocalization
with NPM (Figure 2A). In order to verify a possible associationinduced by cellular oncogenes, such as Ras and Myc (Sherr,
2001), and viral proteins like viral cyclin (K cyclin) expressed by between these proteins, control and MG132 treated cells were
lysed with NP-40 buffer, and the soluble proteins were precipi-Kaposi’s sarcoma-associated herpesvirus (KSHV) (Verschuren
et al., 2002). Ras and Myc increase the levels of ARF, which tated with a HDM2 antibody mix and analyzed by Western blot-
ting. Downregulation of the proteasome led to an increase inbinds HDM2 and translocates it to the nucleoli, relieving the
negative regulation of p53 by HDM2 (Weber et al., 1999, 2000; HDM2 levels and to an association between HDM2 and NPM,
whereas the total levels of NPM were unchanged (Figure 2B).Lohrum et al., 2000). The mechanism of action by which K cyclin
stabilizes and activates p53 is, however, unresolved. The results demonstrate a significant relocalization and in-
creased association of HDM2 with NPM in a p53-independentHere we demonstrate that cellular stress by UV damage
causes NPM nucleoplasmic redistribution and its interaction manner.
To test which functional domains of HDM2 are required forwith HDM2, and that this interaction leads to the stabilization
of p53. We show that NPM also regulates the basal levels of NPM interaction, GST-HDM2 deletion constructs were used in
pulldown assays with in vitro translated 35S-NPM (Figure 2C).p53 in nonstressed cells through its interaction with HDM2. We
find that viral K cyclin utilizes a NPM-mediated pathway for p53 The pulldown assays demonstrated that NPM bound to HDM2-
constructs with amino acid sequences 1–110 containing thestabilization, affecting NPM localization and its interactions with
HDM2 and p53. The results show novel associations between p53 interaction domain and to the HDM2 C terminus harboring
the RING domain, whereas no specific binding was observedNPM, HDM2, and K cyclin, and add a novel mechanism into
the regulation of p53 stability in response to DNA damage and to region 108–280 containing the nuclear localization and export
signals and the acidic domain (Figure 2C). The results indicateviral stress.
that in vitro translated NPM interacts with both N- and C termini
of HDM2. Noting that HDM2 binds to p53 through its N terminusResults
and that NPM has been shown to associate with p53 (Colombo
et al., 2002), we wanted to establish whether NPM affects theNPM is translocated from nucleoli in response
to UV damage complex formation between HDM2 and p53 and to address
a possible competition between these proteins. We thereforeNPM has been described as a UV damage-inducible protein
(Wu and Yung, 2002). In our studies of stress responses of performed an in vitro interaction and competition experiment
by adding to the binding reactions increasing amounts of in vitrocellular proteins we noticed a pronounced rapid shift of NPM
from nucleoli to the nucleoplasm following treatment of SaOS-2 translated p53 and HDM2 and cellular lysate of p53/Mdm2/
murine embryo fibroblasts as a source of NPM. The presenceosteosarcoma cells with UVC radiation (Figure 1A). The translo-
cation was evident by a decrease in the number of NPM-positive of low amounts of p53 in the binding reactions increased the
association of HDM2-NPM, suggesting that p53 promotes thenucleoli and an increase in the nucleoplasmic staining intensity
within 3 hr after the damage (Figures 1A and 1B), and was formation of a trimeric complex (Figure 2D). Higher amounts of
p53, however, decreased the HDM2-NPM association, indicat-observed in a number of cell lines, both wild-type and null for p53
(U2OS and SaOS-2), and in human mortal fibroblasts (WS-1). A ing competition between their binding sites (Figure 2D). As p53
relocalization of NPM following UV damage was also recently binds HDM2 amino acids 19–108, the above results are indica-
reported by Rubbi and Milner (2003). The relocalization of NPM tive that p53 and NPM compete for the binding of HDM2 N
did not result from complete disruption of the nucleolar struc- terminus.
ture, as nucleoli were clearly discernible under phase contrast
(Kurki et al., 2003) and stained with a RNA dye (Syto 12 Green) UV damage-induced NPM-HDM2 complex formation
precedes p53 stabilizationindicating the presence of ribosomal RNA (Figure 1C). The UVC-
induced relocalization of NPM to the nucleoplasmic fraction Given that NPM is a DNA damage-responsive protein and that
it affected HDM2-p53 interaction in vitro, we studied in morewas detected as an increase in the NP-40 soluble fraction and
a decrease of NP-40 insoluble fraction of the cells (Figure 1D). detail the UV-induced effects on HDM2-NPM complex forma-
tion and its impact on p53. WS-1 human fibroblasts and U2OSThere was also a 1.7-fold increase in total NPM as described
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Figure 1. UV radiation causes nucleoplasmic re-
distribution of NPM
A: p53 null SaOS-2 osteosarcoma cells were radi-
ated with UVC (35 J/m2), incubated for the indi-
cated periods of time, fixed, and stained for
NPM. DNA was stained with DAPI.
B: The number of NPM-positive nucleoli and the
mean nucleoplasmic staining intensity of cells
treated as in A was analyzed from 100 cells per
time point.
C: Detection of ribosomal RNA. SaOS-2 cells
treated with UVC and incubated for 16 hr were
stained with Syto 12 Green and for NPM.
D: Analysis of NPM levels in different cellular frac-
tions. SaOS-2 cells were treated as in A. To extract
soluble proteins, cells were lysed with 0.5% NP-
40 lysis buffer, centrifuged, and the supernatant
was collected. Alternatively, the pellet con-
taining insoluble proteins was dissolved to Laem-
mli buffer and boiled. Total cellular extracts were
obtained by lysing the cells in 9 M urea buffer.
Protein concentrations were determined, equal
amounts of proteins were loaded to gels, and
NPM was detected by Western blotting. GAPDH
was included as a protein loading control.
osteosarcoma cells (not shown) were radiated with UVC, and of NPM and HDM2 in response to UV radiation and raise the
possibility that these events affect early p53 stabilization.the levels of total NPM and its interaction with HDM2 were
assessed at several time points (Figure 3). Similarly to SaOS-2
cells, UV stress caused a rearrangment of NPM localization NPM increases HDM2 levels and affects
p53 sumoylationfrom nucleoli to the nucleoplasm and to the outer perinucleolar
region in WS-1 and U2OS cells (Figure 3A and data not shown). NPM has previously been shown to interact with p53 and affect
its activity and stability in response to cellular stress (ColomboCoimmunoprecipitation analyses of the endogenous proteins
demonstrated that HDM2-NPM complex was increased within et al., 2002). Given the notable translocation of NPM to the
nucleoplasm following UV stress and its interaction with HDM2,1–3 hr after the UV damage in both WS-1 and U2OS cells (Figure
3B and data not shown). At this time, p53 starts to accumulate we wanted to test whether the overexpression of NPM affects
HDM2 or p53 levels or localization. In accordance with Colomboand is fully stabilized by 6–12 hr (Figure 4D and Kurki et al.,
2003). Additionally, HDM2-NPM interaction was promoted in et al. (2002), ectopic expression of NPM was found to increase
both p53 and HDM2 (Figures 4A and 4B). However, we findUVC-treated p53/Mdm2/ murine embryo fibroblasts trans-
fected with HDM2 expression vectors, indicating that the in vivo here that NPM increases HDM2 levels in SaOS-2 cells, thus in
a p53-independent manner (Figure 4C). This suggests that NPMregulated HDM2-NPM interaction is independent of p53 (Figure
3C). The results demonstrate a transient increase in association also impinges on HDM2 by other means besides the suggested
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Figure 2. HDM2 interacts with NPM in vivo and
in vitro
A: Inhibition of the proteasome causes HDM2 nu-
cleolar redistribution and NPM colocalization.
SaOS-2 cells were treated with MG132 (10 M)
for 6 hr or left untreated (ctrl), and immuno-
stained for HDM2 and NPM.
B: HDM2 interacts with NPM. Cellular lysates of
SaOS-2 cells, incubated with MG132 for the indi-
cated time or left untreated, were prepared by
lysing the cells with 0.5% NP-40 buffer. HDM2 and
HDM2-NPM complexes were detected by coim-
munoprecipitation followed by blotting for the
respective proteins as indicated, or were ana-
lyzed directly from the NP-40 lysates. GAPDH was
included as a protein loading control.
C: In vitro interaction analyses. GST-HDM2 dele-
tion constructs or full-length HDM2 and irrelevant
GST-vector (GST-CRP1) coupled to glutathione
beads or beads alone were mixed with in vitro
translated 35S-NPM and incubated overnight, fol-
lowed by extensive washing and analysis of the
protein complexes by Western blotting for NPM.
The amount of loaded GST-fusion proteins, indi-
cated by asterisks, was controlled for by Western
blotting of parallel samples for GST.
D: Low levels of p53 augment NPM-HDM2 inter-
action, whereas high levels of p53 decrease
NPM-HDM2 interaction. Cellular lysate (100 g)
from p53/mdm2/ MEFs was mixed with in vitro
translated HDM2 and increasing amounts of
in vitro translated p53 followed by immunopre-
cipitation with HDM2 antibodies and blotting for
NPM. The amounts of reticulosyte lysate in the
reactions were balanced to equal volumes.
increase in transcriptional activity of p53 (Colombo et al., 2002). cells as a 65 kDa insoluble form shortly after UV damage prior
to its stabilization (Kurki et al., 2003). Kinetically, this is alsoSubcellular compartmentalization could pose a means to regu-
late the interaction and levels of p53 and HDM2. However, we the time frame when p53 forms complexes with PML, and is
indicative of a rapid p53 sumoylation event taking place in thecould not detect any change in the nucleoplasmic localization
of p53 or HDM2 in NPM-transfected cells (data not shown). PML-p53 complexes (Kurki et al., 2003). To test whether a
SUMO modification of p53 plays a role in regulating p53-NPMThis indicates that their increase is not a consequence of, e.g.,
nucleolar sequestration as suggested for the ribosomal protein interaction, we treated U2OS cells with UVC and followed p53-
NPM association and their total levels during several time pointsL11-induced effect (Lohrum et al., 2003). In contrast, over-
expression of NPM led to increased complex formation between (Figure 4D). We found that NPM is bound to a slower migrating
65 kDa form of p53 during 1–3 hr following UV treatment, butthe soluble, nucleoplasmic fractions of NPM-p53 and NPM-
HDM2 (Figures 4A and 4B). The fraction of NPM coprecipitating did not bind the 53 kDa form of p53 (Figure 4D). A similar result
was obtained in UV-treated WS-1 fibroblasts (Figure 4E). Towith HDM2 was significantly increased, while there was only a
minor change in the amount of p53 coprecipitating with HDM2 further verify the identity of the 65 kDa protein and its association
with NPM, cellular lysates of UV-treated WS-1 cells were immu-(Figure 4B). This suggests that NPM prefers complex formation
with HDM2, but is unable to dissociate the preformed p53- nodepleted for NPM, followed by immunoprecipitation for p53
and its detection by Western blotting (Figure 4E). The dataHDM2 complexes, at least in unstressed cells.
We have previously noted that p53 is present in UV-treated shows that the 65 kDa p53 form was exhausted at 1 hr time
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Figure 3. HDM2, p53, and NPM complexes undergo changes in response to
UV radiation
A and B: WS-1 cells were radiated with UVC (35 J/m2) and incubated for the
indicated time. A: Localization of NPM was detected by immunostaining.
B: Levels of HDM2 and NPM were detected by Western blotting, and HDM2-
associated NPM was detected by coimmunoprecipitation. Total cellular
extracts were prepared by lysing the cells with 9 M urea buffer. GAPDH was
included as a loading control.
C: p53/mdm2/ murine embryo fibroblasts were transfected with HDM2
and were treated with UVC (35 J/m2) 48 hr after transfection and incubated
for 3 hr. HDM2 levels and HDM2-associated NPM were analyzed by coimmu-
noprecipitation of the cellular lysates.
Figure 4. NPM increases the levels of both p53 and HDM2 and affects p53
sumoylationpoint following NPM depletion, whereas the 53 kDa form of
A and B: U2OS cells were transfected with NPM1 or NPM1.2, and the levelsp53 was not affected. Thus, the data indicates preferential and
of p53, HDM2, NPM, and their complexes were detected by Western blotting
transient interaction of NPM with a 65 kDa form of p53 in UV- or coimmunoprecipitation experiments as indicated. Note that NPM co-
damaged cells. precipitating with p53 has an altered electrophoretic mobility as compared
to NPM present in HDM2 complexes. These could reflect differences in theAs the 65 kDa p53 comigrates with a SUMO-modified p53
phosphorylation pattern or charge of NPM.(Rodriguez et al., 1999; Kurki et al., 2003), we tested whether
C: NPM increases HDM2 levels in a p53-independent manner. SaOS-2 cells
the overexpression of NPM affects p53 sumoylation. For this were transfected with either pSG5 control plasmid (ctrl) or NPM expression
purpose we transfected NPM or, as a comparison, SUMO-1, into vector. Three days after transfection, cells were lysed and precipitated with
a HDM2 antibody mix. HDM2 levels were detected by Western blotting.U2OS cells followed by detection of p53 by immunoprecipitation
D: p53 complexed with NPM has an altered mobility. U2OS cells were treatedand Western blotting (Figure 4F). The results demonstrate that
with UVC (35 J/m2) and incubated for the indicated times. NPM-associated
either ectopic expression of NPM or SUMO-1 alters p53 migra- p53 was detected by coimmunoprecipitation and was compared to p53
tion to a 65 kDa form (Figure 4F). Conversely, immunoprecipita- present in total cellular lysate. p53 present in complex with NPM migrated
as 65 kDa protein.tion of NPM from cells ectopically expressing SUMO-1 followed
E: Depletion of NPM abolishes the 65 kDa form of p53. WS-1 fibroblasts wereby detection of p53 confirmed that NPM interacts with the 65
treated with UVC (35 J/m2) and incubated for the indicated times. Cellular
kDa p53 form. Lastly, NPM was transfected into U2OS cells lysates were immunoprecipitated with a NPM antibody and either sub-
followed by immunoprecipitation for p53 and Western blotting jected to Western blotting for p53 directly (left panel), or the NPM-depleted
lysates were subjected to a second round of immunoprecipitation with afor SUMO-1 (Figure 4F). Ectopic expression of NPM was found
mixture of p53 antibodies (right panel) followed by western blotting for p53to increase SUMO modification of endogenous p53. Based on
(FL-393).
these results, we conclude that NPM associates with p53, but F: NPM increases the amount of SUMO-modified p53. U2OS cells were trans-
prefers the p53 SUMO-modified form. fected with either a NPM or SUMO-1 expression vector as indicated and
incubated for 48 hr. Cellular lysates were prepared and immunoprecipi-
tated with a p53 antibody mix or anti-NPM antibody as indicated, followedDepletion of NPM increases HDM2-p53
by blotting for either p53 or SUMO-1.
complex formation
To test whether the NPM-mediated regulation of p53 occurred
through HDM2, we employed siRNA knockdown approaches.
We transfected U2OS cells with RNAi duplexes targeting NPM
and analyzed the ensuing changes in NPM, HDM2, p53, and
CANCER CELL : MAY 2004 469
A R T I C L E
controls HDM2-p53 interaction and inhibits HDM2-p53 associ-
ation.
To test whether the effect of NPM siRNA on p53 levels was
balanced by depletion of HDM2, we proceeded to knock down
either NPM, HDM2, or both by exposing U2OS cells to respec-
tive RNAi duplexes. Transfection of the cells with HDM2 RNAi
duplexes led to a decrease in HDM2 and an increase in p53
levels as expected (Figure 5D). When the cells were transfected
with duplexes targeting both NPM and HDM2, the decrease in
p53 levels by NPM RNAi was negated, suggesting that depletion
of HDM2 could effectively abrogate the decrease in p53 levels
induced by NPM siRNA (Figure 5D). Surprisingly, HDM2 siRNA
significantly increased the levels of NPM, suggesting that it acts
either directly or indirectly as a negative regulator of NPM.
K cyclin binds NPM and affects its localization
and interactions with HDM2 and p53
KSHV-encoded K cyclin, a viral cyclin D homolog, induces the
stabilization of p53 and sensitizes mouse embryo fibroblasts to
p53-dependent growth arrest and apoptosis (Verschuren et al.,
2002). As NPM interacts with other viral proteins (HIV Rev and
Tat), we wanted to address the possibility that p53 stabilization
in K cyclin-expressing cells is mediated by NPM. U2OS cells
were transfected with a K cyclin expression vector, and its
effects on NPM, HDM2, and p53 were analyzed (Figure 6). Ex-
pression of K cyclin caused a major translocation of NPM from
nucleoli to the nucleoplasm (Figure 6A). However, cyclin D2,
the closest mammalian homolog, was without any effect on NPM
localization (Supplemental Figure S1 at http://www.cancercell.
org/cgi/content/full/5/5/465/DC1). In K cyclin-expressing cells, the
total levels of NPM were unaltered, suggesting that the increase
in the NPM nucleoplasmic fraction is strictly due to its relocaliza-
tion (Figures 6A and 6B). As demonstrated by coimmunoprecipi-
tation analyses, K cyclin and NPM were found to form com-
plexes (Figure 6C). As shown by Verschuren et al. (2002), the
Figure 5. NPM is a negative regulator of p53-HDM2 interaction total level of p53 was increased in K cyclin-expressing cells
A and B: U2OS cells were transfected with NPM or control siRNA duplexes (Figure 6D). In analogy to cells overexpressing NPM, K cyclin
and incubated for 3 days followed by detection of NPM and p53 by immu- increased the levels of HDM2 and the interactions of HDM2 and
nostaining or Western blotting.
NPM (Figure 6E) and p53-NPM (Figure 6D). However, less p53C: Depletion of NPM decreases both basal and UV damage-induced levels
was found to coprecipitate with HDM2 and correlated with theof p53 and increases p53-HDM2 complex formation. NPM siRNA was carried
out as in A. After 3 days, the cells were treated with UVC as indicated and stabilization of p53 in K cyclin-expressing cells (Figure 6E). The
were incubated for 3 hr. p53 and HDM2 or their complexes were analyzed results suggest that NPM interferes with the ability of HDM2 to
by Western blotting and by coimmunoprecipitation. mediate p53 degradation also in response to viral stress and
D: Depletion of HDM2 rescues the negative regulation of p53 by NPM.
reveal a novel mechanism by which p53 is stabilized followingU2OS cells were transfected with HDM2 or NPM siRNA duplexes and were
expression of an oncogenic viral protein.incubated for one and three days, respectively, followed by detection of
NPM, HDM2, or p53 by Western blotting. For depletion of both NPM and
HDM2, the cells were first transfected with NPM RNAi duplexes and incu- Discussion
bated for two days followed by transfection with HDM2 RNAi duplexes.
Similar results were obtained with two sets of HDM2 RNAi duplexes.
HDM2 and NPM interaction or colocalization increased conse-
quent to divergent cellular stresses, like UV damage, protea-
some inhibition, and expression of apoptosis-inducing viral K
cyclin. UV radiation increased the level of NPM and affected its
their complexes (Figure 5). A decrease in NPM was verified by
subcellular localization, causing alterations in p53, HDM2, and
immunofluorescence and by Western blotting (by 40%) (Figures NPM complex formation and p53 stabilization (Figure 7). Our
5A and 5B). We found that depletion of NPM significantly de- data indicates that p53 stabilization is augmented by the rapid
creased both stress-induced levels of p53 (Colombo et al., 2002) UVC-induced nucleoplasmic translocation of NPM and an in-
and p53 basal levels, suggesting that NPM acts both in the crease in nucleoplasmic p53-NPM and HDM2-NPM complexes.
maintenance and stress-induced stabilization of p53 (Figures It is notable that the interaction between NPM and HDM2 or
5B and 5C). Further, the depletion of NPM led to a decrease in p53 was transient, taking place during 1–3 hr after the damage.
HDM2 (by 50%) and, remarkably, to an increase in HDM2-p53 Based on the data, we believe that the dynamic reorganization
of the complexes allows early p53 stabilization and possiblycomplex formation (Figure 5C). The results suggest that NPM
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existence as the protein interactions and their mobility may be
highly dynamic.
The continuous accumulation of nucleoplasmic NPM could
be indicative of its other, possibly DNA damage repair-associ-
ated, functions. Several kinds of DNA-damaging agents, like
doxorubicin, camptothecin, and actinomycin D, cause NPM
translocation (Yung et al., 1985; Chan et al., 1987; Bor et al.,
1992; Chan, 1992), suggesting that its relocalization closely
associates with inhibition of RNA synthesis as also indicated in
a recent study by Rubbi and Milner (2003). A common denomi-
nator for NPM translocation is ribosomal stress, caused either
by direct inhibition of RNA polymerase I (actinomycin D) or
by stalling of RNA polymerase II by bulky UV damage-caused
lesions (Ljungman et al., 1999). Though NPM is a phosphopro-
tein, we have found no evidence that common stress-activated
phosphorylation cascades (p38SAPK, PI3-K related kinases)
would affect its localization (data not shown). Nucleolar proteins
are highly mobile (Phair and Misteli, 2000), and other nucleolar
proteins, like nucleolin, fibrillarin, and Hrad17, demonstrate simi-
lar DNA damage-provoked translocations (Chang et al., 1999;
Daniely et al., 2002; Rubbi and Milner, 2003). Taken together, the
above studies indicate that nucleolar proteins, perhaps signaled
through alterations in ribosome biogenesis evoked by DNA
damage and viral stress, are highly sensitive stress response
proteins and participate in the subsequent cellular damage re-
sponses.
NPM bound to HDM2 N- and C termini, whereas it did not
interact with the central domain. Thus, its binding could affect
p53 stabilization by blocking the HDM2 RING domain with theFigure 6. Viral K cyclin binds NPM, causes NPM redistribution, and affects
p53-HDM2 complex formation E3 ligase activity. This effect may be augmented by binding of
A: K cyclin redistributes NPM. U2OS cells were transfected with Myc-tagged NPM to the HDM2 N terminus and thus hinder p53 interaction.
K cyclin expression vector, and the cells were incubated for 48 hr followed Accordingly, we found that high levels of p53 competed for
by immunostaining for both NPM and K cyclin (anti-Myc). the interaction of NPM and HDM2 and that depletion of NPM
B and C: K cyclin associates with NPM. U2OS cells were transfected with K
increased HDM2-p53 complex formation. NPM acts as a molec-cyclin expression vector as above. Total or soluble fractions of NPM and
ular chaperone, with the tendency to bind denatured substrates,GAPDH as a loading control were analyzed as in Figure 1, or were analyzed
for K cyclin associated NPM. which exposes hydrophobic regions in the NPM-substrate com-
D and E: K cyclin increases p53 and HDM2 association with NPM and dissoci- plex, thus reducing protein aggregation (Szebeni and Olson,
ates p53-HDM2 complexes. U2OS cells were transfected with K cyclin, and 1999). This property could be especially important in the highlycellular lysates were analyzed for levels and interactions of p53 and HDM2.
crowded environment of the nucleolus and could be further
employed in the nucleoplasmic compartment following UV dam-
age of the cells. The chaperone activity of NPM could further
assist p53 folding and stability. It is possible that there alsoassists in its modifications, like sumoylation commencing the
exists selectivity, e.g., regulated by posttranslational modifica-subsequent stabilization effects. We find no evidence favoring
tions of NPM, HDM2, or p53, which determines the sites ofsubcellular trafficking of p53 to the nucleolus following NPM
interaction and types of complexes formed.overexpression (Colombo et al., 2002), but cannot exclude its
The multiple interactions of NPM with cellular proteins sug-
gest that it can act as a platform for protein interactions, affect
their stabilization, or allow protein modifications to take place.
Thus, NPM could stabilize the complex formation between p53,
HDM2, and other proteins needed for their posttranslational
modifications in response to cellular stress. This is supported
by the fact that NPM promotes p53 SUMO modification and
that in response to UV radiation, a SUMO-modified p53 is found
in complex with NPM prior to p53 stabilization. Whether NPM
is essential for SUMO conjugation of p53 in cellular stress needs
to be studied further. NPM could in this way have a dual function
Figure 7. A model for NPM-mediated stabilization of p53 in DNA damage in regulation of p53 activity: by inhibiting p53 degradation
and viral stress
through its interactions with HDM2, and by assembling com-
Both viral stress (K cyclin and adenovirus 5 expression [Matthews, 2001]) and plexes that are needed for p53 modifications augmenting its
DNA-damaging agents (UV radiation, cytotoxic drugs) cause nucleoplas-
activation and stabilization.mic translocation of NPM. Increased nucleoplasmic NPM associates with
both p53 and HDM2 and prevents HDM2-mediated degradation of p53. Here we demonstrate by using both siRNA and overexpres-
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sion approaches that NPM affects p53 stabilization through mors, or alternatively reflected by increased NPM expression
like in melanoma (Bernard et al., 2003) or altered NPM-fusioninhibition of its negative regulator, HDM2. Ectopic NPM in-
creased the levels of both p53 and HDM2, whereas depletion products in promyelocytic leukemia (Alcalay et al., 2001).
Clearly, further studies of expression and regulation of NPM inof NPM by siRNA decreased both the basal and stress-induced
levels of p53 and HDM2 and increased their interaction. The human tumors is warranted.
results indicate that NPM is required for the stabilization of p53
Experimental proceduresand that this is overcome by simultaneous depletion of HDM2
and NPM in UV-damaged cells. Moreover, though the amount
Plasmids
of nucleoplasmic NPM was very low in the untreated cells, it In order to generate GST-HDM2 constructs, regions encoding HDM2 amino
was able to maintain the basal p53 levels as shown by NPM acids 1–110, 108–200, 196–280, and 276–491 were amplified by PCR, using
siRNA. In a similar manner, depletion of NPM by NPM antisense appropriate oligonucleotide primers, and a full-length cDNA encoding HDM2
as template. The PCR products were cloned into the bacterial expressiontransfection has been shown to regulate the levels of PCNA
vector pGEX-2T (Amersham). In a similar manner, the entire coding regionboth in control and UV-treated cells (Wu et al., 2002a). NPM
of HDM2 was also fused downstream of the GST cDNA in pGEX-2T. B23-antisense transfection also potentiates UV-induced cell death
GFP (Dundr et al., 2000) expression vector was a kind gift from Dr. Mark
(Wu et al., 2002a, 2002b). NPM interacts with histones H3 and Olson, and B231.1-pCHA and B231.2-pCHA were kindly provided by Dr.
H4 and has the propensity to cause chromosome decondensa- Kyosuke Nagata (Okuwaki et al., 2001). NPM-pcDNA3 was generated by
tion (Okuwaki et al., 2001), and could in this manner direct EcoRI excision of NPM1.1 from B23-GFP and ligation to pcDNA3. Myc-
tagged K cyclin expression vector was originally received from Dr. Sibylledamage repair-related proteins to the sites of damage. Analo-
Mittnacht (Ellis et al., 1999). SUMO-1 expression vector was from Dr. Jormagous to NPM, ribosomal L11 protein has been connected with
Palvimo. CRP1 cDNA was obtained from American Type Culture Collectionp53 stabilization through inhibition of HDM2 (Lohrum et al.,
(clone no. 6900545), and cloned into pGEX-4T to generate GST-CRP1.2003; Zhang et al., 2003). This event is, however, promoted
through nucleolar sequestration of HDM2 by L11 following inhi- Cells and transfections
bition of RNA polymerase I, and resembles mechanistically the SaOS-2 and U2OS osteosarcoma cells, WS-1 human fibroblasts, and
p53/mdm2/ mouse embryo fibroblasts (Montes de Oca Luna et al.,nucleolar compartmentalization of HDM2 enforced by ARF in
1995) were cultured in a humidified atmosphere containing 5% CO2 at 37Cresponse to oncogenic stress (Sherr and Weber, 2000).
and were transfected by either lipofection (Lipofectamine 2000, Invitrogen)Viral K cyclin caused a pronounced translocation of NPM
or by electroporation (Gene Pulser II, Bio-Rad). Cells were treated with 35to the nucleoplasm and led to NPM interaction with K cyclin.
J/m2 UVC (Stratalinker 2400, Stratagene) and incubated for the given lengths
NPM binds other viral proteins, like the human immunodefi- of time.
ciency virus proteins Tat (Li, 1997) and Rev (Szebeni and Olson,
1999). In fact, the nucleolus and its components may be targeted siRNA
The siRNA duplex sequences used for depletion of NPM were as describedby several viruses, independent of their type or mechanism of
by Colombo et al. (2002), and were purchased from Dharmacon Research,replication (Hiscox, 2002), and therefore, NPM could be a more
Inc. Scrambled NPM siRNA duplexes were used as a control for the siRNAgeneral mediator of viral stress responses. K cyclin expression
reactions. HDM2 RNAi duplexes targeting HDM2 mRNA sequence 5UGGU
led to NPM interaction with p53, HDM2, and K cyclin, and UGCAUUGUCCAUGGC3 and SMARTpool HDM2 siRNA mix were pur-
decreased p53-HDM2 complex formation. We therefore sug- chased from Dharmacon Research, Inc. RNA duplexes (final concentration
gest that NPM-mediated inhibition of HDM2 is responsible for 70 nM) were transfected into the cells by lipofection according to manufactur-
ers protocol (Oligofectamine, Invitrogen). Cells transfected with HDM2 andp53 stabilization in K cyclin-expressing cells. Based on the dif-
NPM siRNA duplexes were incubated for one and three days, respectively. Aferent electrophoretic migration patterns of NPM coprecipitating
decrease in the respective protein levels was verified by immunofluorescencewith K cyclin, p53, and HDM2, it is plausible that these represent
staining and Western blotting.differentially modified forms of NPM. Considering additionally
that K cyclin is apoptotic (Ojala et al., 1999; Verschuren et Immunofluorescence
al., 2002), that adenovirus infection inhibits the synthesis and Cells were fixed with 3.5% paraformaldehyde followed by permeabilization
with 0.5% NP-40. For detection of HDM2, an antibody mix containing theprocessing of rRNA (Castiglia and Flint, 1983) and causes nu-
following primary antibodies was used: IF-2 (Oncogene Sciences), SMP-14cleoplasmic redistribution of NPM (Matthews, 2001), and that
(Santa Cruz Biotechnology), and 2A10. Other primary antibodies were asadenoviruses selectively kill cells with defective p53 function
follows: NPM, C-19 (Santa Cruz Biotechnology) and mouse anti-nucleophos-(McCormick, 2001), one should note that several oncogenic
min (Zymed); Myc-tag, 9E10 (Biosite); p53, FL393 (Santa Cruz Biotech). In
viruses may affect the p53 pathway by causing alterations in coimmunostainings, swine anti-rabbit FITC, rabbit anti-goat FITC or rabbit
the nucleolar functions. anti-mouse TRITC (DAKO), or goat anti-mouse conjugated Alexa 594 or
We propose that NPM is a major factor regulating the levels goat anti-rabbit conjugated Alexa 488 (Molecular Probes) were used as
fluorochromes, and DNA was stained with 4,6-diamidino-2-phenylindoleof p53 through HDM2 and possibly also the modification of p53.
(DAPI, Molecular Probes) and RNA with Syto 12 green fluorescent nucleicAfter exposure of cells to DNA damage or viral insult, NPM is
acid stain (Molecular Probes). Absence of crossreactivity of the antibodiestranslocated from the nucleoli to the nucleoplasm, where it binds
and conjugates was verified in separate experiments. The fluorochromes
HDM2, thereby inhibiting p53 degradation by affecting p53- were visualized with Zeiss Axioplan 2 Imaging MOT (Jena, Germany)
HDM2 complex formation (Figure 7). How stress signal path- equipped with appropriate filters (Chroma) with 63 magnification, and im-
ways are needed to modulate the interactions between HDM2, ages were captured with Zeiss Axiocam CCD-videocamera followed by
image processing and multilayer analysis with AxioVision program versionNPM, and p53 needs further studies. However, it seems clear
3.0. Quantitation of the staining intensities was performed by KS Run 3.0that highly controlled regulation of NPM is essential and reflects
analysis program (KS 400, Zeiss) from 100 nuclei per time point.the fate of p53 to either become stabilized or degraded. We
find it highly significant that both oncogenic viruses and genomic Immunoprecipitation and immunoblotting
damage employ a common nucleolar protein for this purpose. Cells were lysed into NP-40 lysis buffer containing 25 mM Tris-HCl (pH 8.0),
120 mM NaCl, 0.5% NP-40, 4 mM NaF, 100M Na3VO4, 1 mM phenylmethyl-The control enforced by NPM may consequently be lost in tu-
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Barak, Y., and Oren, M. (1992). Enhanced binding of a 95 kDa protein to p53sulfonyl fluoride, 100 KIU/ml aprotinin, and 10 g/ml leupeptin. Cellular NP-
in cells undergoing p53-mediated growth arrest. EMBO J. 11, 2115–2121.40 lysate was separated to insoluble and soluble fractions by centrifugation.
The insoluble pellet fraction was boiled in LSB containing dithiothreitol (100 Bernard, K., Litman, E., Fitzpatrick, J.L., Shellman, Y.G., Argast, G., Polvinen,
mM). To obtain total cellular lysates, cells were resuspended in urea-Tris K., Everett, A.D., Fukasawa, K., Norris, D.A., Ahn, N.G., and Resign, K.A.
buffer (9 M urea, 75 mM Tris-HCl [pH 7.5] and 0.15 M 2-mercaptoethanol) (2003). Functional proteomic analysis of melanoma progression. Cancer Res.
and sonicated briefly. Total protein concentration was determined by Bio- 63, 6716–6725.
Rad protein assay (Bio-Rad, Hercules, CA). Protein concentrations of NP-
Bor, A.M., Chang, F.J., and Yung, B.Y. (1992). Phosphoprotein B23 translo-40 lysates were determined by Bio-Rad Dc protein assay kit (Bio-Rad, Her-
cation and modulation of actinomycin D and doxorubicin cytotoxicity bycules, CA) and after normalization of the protein concentrations, lysates
dipyridamole in HeLa cells. Int. J. Cancer 52, 658–663.were immunoprecipitated with specific antibodies (NPM, anti-nucleophos-
min; HDM2, mix of IF-2, SMP-14, and 2A10; and p53, an antibody mix of Borer, R.A., Lehner, C.F., Eppenberger, H.M., and Nigg, E.A. (1989). Major
DO-1, 421, and 1801). The immunocomplexes were collected on nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56, 379–390.
GammaBind-G Sepharose (Pharmacia Biotech). Cellular lysates or immuno-
Castiglia, C.L., and Flint, S.J. (1983). Effects of adenovirus infection on rRNAcomplexes were separated by 9% or 12.5% sodium dodecyl sulfate-poly-
synthesis and maturation in HeLa cells. Mol. Cell. Biol. 3, 662–671.acrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose
membrane (Trans-Blot, Transfer Medium, Bio-Rad). Immunoblotting was Chan, P.K. (1992). Characterization and cellular localization of nucleophos-
carried out by using mouse anti-nucleophosmin (Zymed), the above HDM2 min/B23 in HeLa cells treated with selected cytotoxic agents (studies of
antibody mix, FL-393 (Santa Cruz Biotechnology) for p53, mouse anti- B23-translocation mechanism). Exp. Cell Res. 203, 174–181.
SUMO-1 (GMP-1, Zymed), mouse anti-ubiquitin (P4D1, Santa Cruz Biotech-
Chan, P.K., Aldrich, M.B., and Yung, B.Y. (1987). Nucleolar protein B23nology), GAPDH (Europa Bioproducts, Cambridge, UK), and monoclonal
translocation after doxorubicin treatment in murine tumor cells. Cancer Res.anti-GST (clone BC8E8), followed by secondary antibodies containing horse-
47, 3798–3801.
radish peroxidase (HRP), after which the proteins were detected with en-
hanced chemiluminescence (ECL, Amersham Life Sciences). Chang, J.H., and Olson, M.O. (1989). A single gene codes for two forms of
rat nucleolar protein B23 mRNA. J. Biol. Chem. 264, 11732–11737.
In vitro translation and competition assays
Chang, M.S., Sasaki, H., Campbell, M.S., Kraeft, S.K., Sutherland, R., Yang,
HDM2, p53, and NPM were translated in vitro (TnT coupled Reticulosyte
C.Y., Liu, Y., Auclair, D., Hao, L., Sonoda, H., et al. (1999). Hrad17 colocalizes
lysate system, Promega) in the presence of 20Ci of 35S-methionine (specific with NHP2L1 in the nucleolus and redistributes after UV radiation. J. Biol.
activity 1000 Ci/mmol, Amersham) when indicated, mixed, and incubated Chem. 274, 36544–36549.
for 90 min at 30C. In competition assays, in vitro translated p53 and HDM2
Colombo, E., Marine, J.C., Danovi, D., Falini, B., and Pelicci, P.G. (2002).were mixed with a lysate from p53/mdm2/ murine embryo fibroblasts
Nucleophosmin regulates the stability and transcriptional activity of p53.and the amounts of reticulosyte lysate added to the reactions were balanced
Nat. Cell Biol. 4, 529–533.to equal volumes. Subsequently, the mixes were precipitated with HDM2 an-
tibodies followed by analyses of the protein complexes by Western blotting. Daniely, Y., Dimitrova, D.D., and Borowiec, J.A. (2002). Stress-dependent
nucleolin mobilization mediated by p53-nucleolin complex formation. Mol.
GST pulldown assays Cell. Biol. 22, 6014–6022.
The encoded HDM2 GST-fusion proteins and full-length HDM2 and irrelevant
Dundr, M., Misteli, T., and Olson, M.O. (2000). The dynamics of postmitoticGST-protein control (GST-CRP1) were expressed in BL-21 cells following
reassembly of the nucleolus. J. Cell Biol. 150, 433–446.induction with IPTG. The fusion proteins were captured on glutathione-
Sepharose 4B beads (Amersham) for the GST pulldown experiments, and Ellis, M., Chew, Y.P., Fallis, L., Freddersdorf, S., Boshoff, C., Weiss, R.A.,
in vitro translated 35S-NPM was added. Binding was performed in TNE-buffer Lu, X., and Mittnacht, S. (1999). Degradation of p27(Kip) cdk inhibitor trig-
(140 mM NaCl, 0.5% Nonidet P-40, 50 mM Tris-HCl [pH 8.0], 1 mM EDTA, gered by Kaposi’s sarcoma virus cyclin-cdk6 complex. EMBO J. 18, 644–
and 1 mM PMSF) overnight under rotation at 4C, and the beads were 653.
washed ten times with TNE-buffer and finally with PBS. Beads were boiled
Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., and Weissman, A.M.in 1 LSB containing dithiothreitol (100 mM) for 5 min, and the supernatant
(2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itselfwas loaded to gels followed by autoradiography. The amount of GST-HDM2
and p53. J. Biol. Chem. 275, 8945–8951.fusion products and GST-controls used in the reactions were controlled by
Western blotting of parallel samples with antibody against GST. Fankhauser, C., Izaurralde, E., Adachi, Y., Wingfield, P., and Laemmli, U.K.
(1991). Specific complex of human immunodeficiency virus type 1 rev and
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